{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:30:34Z","timestamp":1793896234662,"version":"4.8.0"},"reference-count":14,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,3,24]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Patients with mantle cell lymphoma who progressed during treatment with ibrutinib have a poor outcome. There are no therapies that appear to be uniquely successful in the postibrutinib setting. The postibrutinib setting is an unmet need.<\/jats:p>","DOI":"10.1182\/blood-2015-10-673145","type":"journal-article","created":{"date-parts":[[2016,1,14]],"date-time":"2016-01-14T05:31:55Z","timestamp":1452749515000},"page":"1559-1563","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":273,"title":["Postibrutinib outcomes in patients with mantle cell lymphoma"],"prefix":"10.1182","volume":"127","author":[{"given":"Peter","family":"Martin","sequence":"first","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kami","family":"Maddocks","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Leonard","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Ruan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Goy","sequence":"additional","affiliation":[{"name":"Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Wagner-Johnston","sequence":"additional","affiliation":[{"name":"Division of Oncology, Washington University School of Medicine, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Rule","sequence":"additional","affiliation":[{"name":"Department of Haematology, Plymouth University Peninsula Schools of Medicine and Dentistry and Derriford Hospital, Plymouth, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana","family":"Advani","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Iberri","sequence":"additional","affiliation":[{"name":"Stanford Cancer Institute, Stanford, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tycel","family":"Phillips","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Michigan, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Spurgeon","sequence":"additional","affiliation":[{"name":"Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Kozin","sequence":"additional","affiliation":[{"name":"Center for Hematologic Malignancies, Oregon Health and Science University, Portland, OR;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Noto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Jurczak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Jagiellonian University, Krakow, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Auer","sequence":"additional","affiliation":[{"name":"St. Bartholomew's Hospital, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Chmielowska","sequence":"additional","affiliation":[{"name":"Oddzial Kliniczny Onkologii, Bydgoszcz, Poland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Bloehdorn","sequence":"additional","affiliation":[{"name":"Universit\u00e4tsklinikum Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Portell","sequence":"additional","affiliation":[{"name":"University of Virginia Cancer Center, Charlottesville, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E.","family":"Williams","sequence":"additional","affiliation":[{"name":"University of Virginia Cancer Center, Charlottesville, VA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Dreyling","sequence":"additional","affiliation":[{"name":"Klinikum der Universit\u00e4t M\u00fcnchen, Munich, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Barr","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Rochester Medical Center, Rochester, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Chen-Kiang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"DiLiberto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Weill Cornell Medical College, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Furman","sequence":"additional","affiliation":[{"name":"Department of Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristie A.","family":"Blum","sequence":"additional","affiliation":[{"name":"Ohio State University Comprehensive Cancer Center, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2019111902373155400_B1","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMoa1306220","article-title":"Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.","volume":"369","author":"Wang","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111902373155400_B2","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood-2015-03-635326","article-title":"Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"21","key":"2019111902373155400_B3","article-title":"Efficacy and safety of single-agent ibrutinib in patients with mantle cell lymphoma who progressed after bortezomib therapy [abstract].","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2019111902373155400_B4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1158\/2159-8290.CD-14-0098","article-title":"Cell-cycle reprogramming for PI3K inhibition overrides a relapse-specific C481S BTK mutation revealed by longitudinal functional genomics in mantle cell lymphoma.","volume":"4","author":"Chiron","year":"2014","journal-title":"Cancer Discov"},{"issue":"1","key":"2019111902373155400_B5","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nm.3435","article-title":"Pharmacological and genomic profiling identifies NF-\u03baB-targeted treatment strategies for mantle cell lymphoma.","volume":"20","author":"Rahal","year":"2014","journal-title":"Nat Med"},{"issue":"21","key":"2019111902373155400_B6","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.78.78","article-title":"Mutational analysis of patients with primary resistance to single-agent ibrutinib in relapsed or refractory mantle cell lymphoma (MCL) [abstract].","volume":"124","author":"Balasubramanian","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2019111902373155400_B7","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2014-09-603670","article-title":"Outcomes of patients with chronic lymphocytic leukemia after discontinuing ibrutinib.","volume":"125","author":"Jain","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2019111902373155400_B8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/annonc\/mdv111","article-title":"Patients with mantle cell lymphoma failing ibrutinib are unlikely to respond to salvage chemotherapy and have poor outcomes.","volume":"26","author":"Cheah","year":"2015","journal-title":"Ann Oncol"},{"issue":"27","key":"2019111902373155400_B9","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"2019111902373155400_B10","first-page":"33","article-title":"Prognostic value of proliferation, cytology, and growth pattern in mantle cell lymphoma: results from randomized trials of the European MCL Network [abstract].","author":"Hoster","year":"2015","journal-title":"Hematol Oncol"},{"issue":"24","key":"2019111902373155400_B11","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1056\/NEJMoa1400029","article-title":"Resistance mechanisms for the Bruton\u2019s tyrosine kinase inhibitor ibrutinib.","volume":"370","author":"Woyach","year":"2014","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111902373155400_B12","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/nm.3884","article-title":"Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"issue":"Suppl 1","key":"2019111902373155400_B13","article-title":"Genetic heterogeneity and clonal evolution in primary and relapsed mantle cell lymphomas [abstract].","volume":"33","author":"Pan-Hammarstr\u00f6m","year":"2015","journal-title":"Hematol Oncol"},{"issue":"2","key":"2019111902373155400_B14","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/his.12009","article-title":"Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.","volume":"62","author":"Vogt","year":"2013","journal-title":"Histopathology"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/12\/1559\/1392437\/1559.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/12\/1559\/1392437\/1559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T07:39:14Z","timestamp":1574149154000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/12\/1559\/35048\/Postibrutinib-outcomes-in-patients-with-mantle"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,24]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,3,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-10-673145","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,24]]}}}